Hatteras Venture Advisors III LLC 13D and 13G filings for Clearside Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-04 4:15 pm Sale | 2022-12-15 | 13D | Clearside Biomedical, Inc. CLSD | Hatteras Venture Advisors III LLC | 243,604 6.100% | -90,724 (-27.14%) | Filing |